Back to today’s briefing

Story perspectives

Reviving Aged T Cells: Key to Enhanced Cancer Therapy

5/20/2025

42 8

Summary

Story summary

Swiss researchers have uncovered a crucial link between declining NAD levels and T cell dysfunction in older cancer patients, which hampers the effectiveness of CAR-T cell therapy. By restoring NAD levels, they successfully rejuvenated aged T cells, boosting their ability to fight tumors. This groundbreaking study highlights the importance of tailoring immunotherapies for the aging population.

1 of 1

Story summary

Swiss researchers have uncovered a crucial link between declining NAD levels and T cell dysfunction in older cancer patients, which hampers the effectiveness of CAR-T cell therapy. By restoring NAD levels, they successfully rejuvenated aged T cells, boosting their ability to fight tumors. This groundbreaking study highlights the importance of tailoring immunotherapies for the aging population.